ConductScience.org, home

Library / Trials

Silicone Gel Versus White Petrolatum After Fractional CO₂ Laser

NCT07930286, Phase 4, Completed, University Medical Center Ho Chi Minh City (UMC)

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleSilicone Gel Versus White Petrolatum After Fractional CO₂ LaserClinicalTrials.gov
NCT numberNCT07930286ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesPhase 4ClinicalTrials.gov
Enrollment39 participants, actualClinicalTrials.gov
Lead sponsorUniversity Medical Center Ho Chi Minh City (UMC)ClinicalTrials.gov
ConditionsAcne Scars, Acne Scars - AtrophicClinicalTrials.gov
InterventionsSilicone Gels, Petrolatum OintmentClinicalTrials.gov
First posted2026-11-12ClinicalTrials.gov
Last updated2026-11-12ClinicalTrials.gov

Registered outcomes 5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryScar severityBaseline and 1, 2, 6 weeks post-treatmentScar severity graded with the ECCA (Clinical Evaluation Scale for Acne Scars) score. Total score range: 0 to 540 points. Higher scores mean more severe scarring.ClinicalTrials.gov
SecondaryOverall improvementBaseline and 1, 2, 6 weeks post-treatment
Overall improvement graded by two blinded dermatologists using the Physician Global Aesthetic Improvement Scale (PGAIS). The PGAIS typically uses a 5-point grading system comparing post-treatment results to baseline photographs or pre-treatment appearance; from "Much improved" to "Much worse".
ClinicalTrials.gov
SecondarySkin hydrationBaseline and 1, 2, 6 weeks post-treatmentSkin hydration index was measured with Corneometer probe (Courage + Khazaka)ClinicalTrials.gov
SecondaryTransepidermal Water LossBaseline and 1, 2, 6 weeks post-treatmentTransepidermal Water Loss index was measured with Tewameter probe (Courage + Khazaka)ClinicalTrials.gov
SecondaryErythemaBaseline and 1, 2, 6 weeks post-treatmentErythema index was measured with Mexameter probe (Courage + Khazaka)ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 4

FieldValueSource
Releasetrials-2026-11-12-0.3.0ClinicalTrials.gov
Release manifest SHA-2564a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.3.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.